WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

New Drugs Are Replacing Chemo for Aggressive Breast Cancer

AstraZeneca and Gilead have won approval for treatments of an advanced form of the disease.

Raccontata daendpoints.newshindustantimes.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
hindustantimes.comStai leggendo11 h fa

New Drugs Are Replacing Chemo for Aggressive Breast Cancer

AstraZeneca and Gilead have won approval for treatments of an advanced form of the disease.

originale
endpoints.news1 g fa

FDA backs Gilead’s Trodelvy for first-line, triple-negative breast cancer

FDA grants Gilead two first-line approvals for Trodelvy in triple-negative breast cancer, broadening its reach beyond Datroway's narrower indication.

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 24 giugno 2026·endpoints.news

    FDA backs Gilead’s Trodelvy for first-line, triple-negative breast cancer

    FDA grants Gilead two first-line approvals for Trodelvy in triple-negative breast cancer, broadening its reach beyond Datroway's narrower indication.

  2. giovedì 25 giugno 2026·hindustantimes.com

    New Drugs Are Replacing Chemo for Aggressive Breast Cancer

    AstraZeneca and Gilead have won approval for treatments of an advanced form of the disease.